mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.6 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.6 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |